growth/size/body
• males exhibit decreased body weight at 10 and 14 days of age but not at 10 days indicating decreased postnatal growth
• treatment with copper does not affect body weight
|
pigmentation
• white fur
|
behavior/neurological
homeostasis/metabolism
N |
• urate oxidase activity in the liver is normal
|
• copper content in the small and large intestine is increased
|
• copper content in the heart is decreased
|
• copper content in the cerebrum, cerebellum and brain stem is decreased
|
• liver copper content is decreased in 7 to 14 day old males
(J:1132)
• treatment with copper increases liver copper content
(J:1132)
(J:12745)
|
• cytochrome c oxidase activity in the brain (cerebrum, cerebellum, brain stem) and heart is decreased
• however, cytochrome c oxidase activity in the lung, spleen, thymus, intestine, kidney and liver is not affected
|
digestive/alimentary system
• large intestine weight is lower in 10 day old mice
• copper treatment increases large intestine weight
|
hematopoietic system
• spleen weight is lower in 10 day old mice
• copper treatment increases spleen weight
|
liver/biliary system
• liver copper content is decreased in 7 to 14 day old males
(J:1132)
• treatment with copper increases liver copper content
(J:1132)
(J:12745)
|
immune system
• spleen weight is lower in 10 day old mice
• copper treatment increases spleen weight
|
integument
• white fur
|
nervous system
• copper content in the cerebrum, cerebellum and brain stem is decreased
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Menkes disease | DOID:1838 |
OMIM:309400 |
J:1132 , J:12745 |